Neuroendocrine Tumors
📧 Sign up to get email alerts when something new happens for Neuroendocrine Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-06-10Clinical Trial Update: A Study to testABI-009 in Patients With Metastatic, Unresectable, Low or Intermediate Grade Neuroendocrine Tumors of the Lung or Gastroenteropancreatic System [Phase 2]
Phase 2 study of ABI-009 in metastatic, unresectable neuroendocrine tumors of the lung or gastrointestinal system was terminated.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Safety of 68Ga-DOTA-tyr3-Octreotide PET in Diagnosis of Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the safety of 68Ga-DOTA-tyr3-Octreotide PET in diagnosing solid tumors has completed with posted results…
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas [Phase 2, Phase 3]
Clinical trial update for Sandostatin LAR and Axitinib vs placebo in advanced well-differentiated non-pancreatic neuroendocrine carcinomas, …
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating Ga-68 DOTATOC PET-CT imaging in the management of neuroendocrine tumors has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-04Clinical Trial Update: Personalized CAPTEM Radiopeptide Therapy of Advanced, Non-resectable Neuroendocrine Cancer [Phase 2]
Phase 2 trial update on personalized CAPTEM radiopeptide therapy for advanced, non-resectable neuroendocrine tumors.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-10-01Clinical Trial Update: Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neuroendocrine Tumors. [Phase 2]
Phase 2 trial assessing efficacy and safety of Lanreotide Autogel in combination with Temozolomide for thoracic neuroendocrine tumors; trial…
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery [Phase 2]
Phase 2 trial evaluating mutation-targeted therapy with sunitinib or everolimus in advanced low- or intermediate-grade neuroendocrine tumors…
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: A Study to Assess the Safety and the Efficacy of the Combination of TH-302 and Sunitinib in Neuroendocrine Pancreatic Tumours [Phase 2]
Phase 2 trial assessing safety and efficacy of TH-302 in combination with sunitinib for neuroendocrine pancreatic tumors has completed with …
-
CLINICAL_TRIALS trial_result · 2020-06-17Clinical Trial Update: A Study of Anlotinib and AK105 Injection in Subjects With Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors [Phase 2]
Phase 2 clinical trial update for anlotinib and AK105 injection in patients with gastrointestinal, urinary system, and neuroendocrine tumors…
-
CLINICAL_TRIALS trial_result · 2020-03-09Clinical Trial Update: Study Escalating Doses of PM01183 in Combination With Fixed Doxorubicin in Patients With Specific Advanced Unresectable Solid Tumors [Phase 1]
Phase 1 trial evaluating escalating doses of PM01183 in combination with fixed doxorubicin in advanced unresectable solid tumors; study comp…
-
CLINICAL_TRIALS trial_result · 2020-03-05Clinical Trial Update: Beta- Probe and Surgery in GEP NET: Evaluation of a New Probe [Phase 2]
Phase 2 clinical trial evaluating beta-probe and surgery in neuroendocrine tumors has completed.
-
CLINICAL_TRIALS trial_result · 2020-02-07Clinical Trial Update: Efficacy and Safety of 177Lu-Dotatate PRRT in Metastatic GEP-NEN Patients [Phase 2]
Phase 2 trial update evaluating efficacy and safety of 177Lu-Dotatate PRRT in metastatic gastroenteropancreatic neuroendocrine tumors.
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Pembrolizumab for the Treatment of Recurrent High Grade Neuroendocrine Carcinoma [Phase 2]
Phase 2 trial investigating pembrolizumab for recurrent high-grade neuroendocrine carcinoma (neuroendocrine tumors) has been terminated with…
-
CLINICAL_TRIALS trial_result · 2019-10-25Clinical Trial Update: Sandostatin (Octreotide LAR) May Lead to Clinical Improvement Through Receptor Occupation Optimisation [Phase 4]
Phase 4 trial update for Sandostatin (octreotide LAR) evaluating potential clinical improvement via receptor occupation optimization in neur…
-
CLINICAL_TRIALS trial_result · 2019-06-07Clinical Trial Update: Circulating Tumour Cells in Somatuline Autogel Treated NeuroEndocrine Tumours Patients [Phase 4]
Phase 4 clinical trial update on circulating tumor cells in patients with neuroendocrine tumours treated with Somatuline Autogel.
-
CLINICAL_TRIALS trial_result · 2019-05-20Clinical Trial Update: Study of Lanreotide in Metastatic or Recurrent Grade I-II Hindgut NET [Phase 4]
Phase 4 study investigating lanreotide in metastatic or recurrent grade I-II hindgut neuroendocrine tumors.
-
CLINICAL_TRIALS trial_result · 2019-04-02Clinical Trial Update: Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating 68Gallium-DOTATATE PET/CT for detecting neuroendocrine tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-03-04Clinical Trial Update: Pazopanib as Single Agent in Advanced NETs [Phase 2]
Phase 2 trial of pazopanib as a single agent in advanced/metastatic neuroendocrine tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: Efficacy Study of Sorafenib and Cyclophosphamide to Treat Neuroendocrine Tumors [Phase 2]
Phase 2 efficacy trial assessing a combination of sorafenib and cyclophosphamide in patients with neuroendocrine tumors. Results have been p…
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: Diagnosis and Staging of Neuroendocrine Tumors (NETs) Utilizing 68Ga-DOTATOC PET/CT Scan [Phase 3]
A Phase 3 clinical trial evaluating the use of 68Ga-DOTATOC PET/CT for diagnosis and staging of neuroendocrine tumors has completed with res…
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients [Phase 1, Phase 2]
Phase 1/2 dose-finding study of TKM-080301 infusion in neuroendocrine tumors and adrenocortical carcinoma has been completed.
-
CLINICAL_TRIALS trial_result · 2018-08-14Clinical Trial Update: Treatment of Neuroendocrine Tumors (NETs) With Combination of Everolimus and Radiolabeled Somatostatin Analogue [Phase 1, Phase 2]
A clinical trial update on combining everolimus with a radiolabeled somatostatin analogue for neuroendocrine tumors across Phase 1 and Phase…
-
CLINICAL_TRIALS trial_result · 2018-07-30Clinical Trial Update: Safety and Pharmacology of SNX-5422 Plus Everolimus in Subjects With Neuroendocrine Tumors [Phase 1]
A Phase 1 trial assessing safety and pharmacology of SNX-5422 plus Everolimus in neuroendocrine tumors has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer [Phase 2]
Phase 2 clinical trial update for cixutumumab (IMC-A12) in islet cell cancer, with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Rollover Protocol for Subjects Who Have Responded on Study 4218s - A Phase 2 Study [Phase 2]
Clinical trial update outlines a rollover protocol for subjects who responded in Mateon Therapeutics' Phase 2 neuroendocrine tumor study 421…